Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma

PURPOSE: More than 80% of patients who undergo sentinel lymph node (SLN) biopsy have no nodal metastasis. Here, we describe a model that combines clinicopathologic and molecular variables to identify patients with thin- and intermediate-thickness melanomas who may forgo the SLN biopsy procedure beca...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellomo, Domenico, Arias-Mejias, Suzette M., Ramana, Chandru, Heim, Joel B., Quattrocchi, Enrica, Sominidi-Damodaran, Sindhuja, Bridges, Alina G., Lehman, Julia S., Hieken, Tina J., Jakub, James W., Pittelkow, Mark R., DiCaudo, David J., Pockaj, Barbara A., Sluzevich, Jason C., Cappel, Mark A., Bagaria, Sanjay P., Perniciaro, Charles, Tjien-Fooh, Félicia J., van Vliet, Martin H., Dwarkasing, Jvalini, Meves, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220172/
https://www.ncbi.nlm.nih.gov/pubmed/32405608
http://dx.doi.org/10.1200/PO.19.00206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220172/
https://www.ncbi.nlm.nih.gov/pubmed/32405608
http://dx.doi.org/10.1200/PO.19.00206

Ejemplares similares